The topology of our model encompasses signal transduction pathways frequently dysregulated in cancer (MAPK/ERK, PI3K/AKT and TAK1/NF-kB), as well as pathways underlying DNA compromising and repair effects of two chemotherapeutic agents (5FU, oxaliplatin). This evidence concerns the gene AKT1 and cancer.